U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 7 of 7 results

Status:
US Approved Rx (2003)
First approved in 2003

Class (Stereo):
CHEMICAL (ACHIRAL)



NAMENDA (marketed under the brands Namenda among others) is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Persistent activation of central nervous system N-methy...
Status:
US Approved Rx (2024)
First approved in 2001

Class (Stereo):
CHEMICAL (ABSOLUTE)



Galantamine (RAZADYNE®, galantamine hydrobromide) is a benzazepine derived from norbelladine. It is found in Galanthus and other Amaryllidaceae. It is a reversible, competitive acetylcholinesterase inhibitor that is used for the treatment of mild to ...
Status:
US Approved Rx (2018)
First approved in 2000

Class (Stereo):
CHEMICAL (ABSOLUTE)



Rivastigmine (sold under the trade name Exelon) is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. Rivastigmine, an acetylcholinesterase inhibi...
Status:
US Approved Rx (2016)
First approved in 1996

Class (Stereo):
CHEMICAL (RACEMIC)



Donepezil, marketed under the trade name Aricept, is a medication used in the palliative treatment of Alzheimer's disease. Aricept is indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mil...
Status:
US Previously Marketed
First approved in 1993

Class (Stereo):
CHEMICAL (ACHIRAL)



Tacrine is a parasympathomimetic- a reversible cholinesterase inhibitor that is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. An early pathophysiological feature of Alzheimer's disease that is associated with memor...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ACHIRAL)



Ipidacrine (Neiromidin) is a drug first synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. Neuromidin has a direct stimulating effect on the conduct of the pulse along the nerve fibers, interneuro...
structurally diverse
Status:
Possibly Marketed Outside US
First approved in 1999

Class:
STRUCTURALLY DIVERSE